Researchers conducted a retrospective study published in June 2025 issue of Rheumatology International to compile evidence on sex-specific differences in systemic lupus erythematosus (SLE), focusing ...

Intravenous belimumab plus SOC vs placebo plus SOC was not linked to an increased risk for infection among patients with SLE.

A team studied the differences between monogenic and nonmonogenic lupus nephritis and the predictors of end-stage kidney disease. Monogenic lupus nephritis is distinct from non-monogenic disease with ...

Serum S100A8/A9 levels are “significantly higher’ among patients with cognitive impairment in systemic lupus erythematosus, ...

Guidelines recommend minimizing glucocorticoid exposure in patients with lupus (SLE), and research suggests this advice should also apply to those with lupus nephritis.

In the Belimumab in Subjects with Systemic Lupus Erythematosus (BLISS)-BELIEVE Study, combination therapy was not superior to belimumab add-on therapy in non-renal SLE, although a clinical benefit was ...